Literature DB >> 7291234

The aversive stimulus properties of repeated infusions of cocaine.

R W Foltin, K L Preston, G C Wagner, C R Schuster.   

Abstract

When the presentation of a novel food to a rat is followed by the administration of certain compounds, including psychomotor stimulants, the animal consumes less of the food on subsequent presentations relative to an animal administered saline. This phenomenon has been termed gustatory avoidance conditioning. Conflicting results have been obtained when cocaine is used in this procedure. Therefore, the possibility that the weak efficacy of cocaine in this paradigm is due to its relatively short duration of action was investigated. Fluid intake was limited to a single 15 min presentation, seven days a week. Following the determination of baseline water in take sweetened milk was given during the session followed by a series of infusions of cocaine through chronic indwelling peritoneal catheters. Four infusions, spaced 15 min apart, of 9.0 mg/kg cocaine induced an avoidance response, while one infusion of 36 mg/kg cocaine followed by three saline infusions did not. This supports the hypothesis that the low efficacy of cocaine in this paradigm is due, at least in part, to its short duration of action.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7291234     DOI: 10.1016/0091-3057(81)90341-5

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

1.  Genetic and early environmental contributions to alcohol's aversive and physiological effects.

Authors:  Peter G Roma; Jennifer A Rinker; Katherine M Serafine; Scott A Chen; Christina S Barr; Kejun Cheng; Kenner C Rice; Anthony L Riley
Journal:  Pharmacol Biochem Behav       Date:  2008-06-29       Impact factor: 3.533

2.  Rewarding and aversive properties of IP and SC cocaine: assessment by place and taste conditioning.

Authors:  L A Mayer; L A Parker
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.